Literature DB >> 28703341

Esophageal function testing: Billing and coding update.

A Khan1, B Massey2, S Rao3, J Pandolfino4.   

Abstract

BACKGROUND AND
PURPOSE: Esophageal function testing is being increasingly utilized in diagnosis and management of esophageal disorders. There have been several recent technological advances in the field to allow practitioners the ability to more accurately assess and treat such conditions, but there has been a relative lack of education in the literature regarding the associated Common Procedural Terminology (CPT) codes and methods of reimbursement. This review, commissioned and supported by the American Neurogastroenterology and Motility Society Council, aims to summarize each of the CPT codes for esophageal function testing and show the trends of associated reimbursement, as well as recommend coding methods in a practical context. We also aim to encourage many of these codes to be reviewed on a gastrointestinal (GI) societal level, by providing evidence of both discrepancies in coding definitions and inadequate reimbursement in this new era of esophageal function testing.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  billing; coding; impedance testing; manometry; pH testing

Mesh:

Year:  2017        PMID: 28703341     DOI: 10.1111/nmo.13158

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  2 in total

1.  Routine esophageal manometry is not useful in patients with normal videoesophagram.

Authors:  Evan T Alicuben; Nikolai Bildzukewicz; Kamran Samakar; Namir Katkhouda; Adrian Dobrowolsky; Kulmeet Sandhu; John C Lipham
Journal:  Surg Endosc       Date:  2018-09-24       Impact factor: 4.584

2.  American Neurogastroenterology and Motility Society Task Force Recommendations for Resumption of Motility Laboratory Operations During the COVID-19 Pandemic.

Authors:  Jason R Baker; Baha Moshiree; Satish Rao; Leila Neshatian; Linda Nguyen; William D Chey; Richard Saad; Jose M Garza; Shamaila Waseem; Abraham R Khan; John E Pandolfino; C Prakash Gyawali
Journal:  Am J Gastroenterol       Date:  2020-10       Impact factor: 12.045

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.